Indian drug manufacturers Lupin, Glenmark, and Dr. Reddy’s Laboratories are recalling their products in the US market due to deviations in CGMP (current good manufacturing practices). Lupin is recalling a lot of losartan. Glenmark is recalling zonisamide and Dr. Roddy’s has recalled lansoprazole.